Chen W, Zhong Y, Yuan Y, Zhu M, Hu W, Liu N
Genes Dis. 2023; 10(6):2457-2469.
PMID: 37554201
PMC: 10404878.
DOI: 10.1016/j.gendis.2022.10.029.
Anderson 3rd D, Grajales-Reyes G, Satpathy A, Vasquez Hueichucura C, Murphy T, Murphy K
Eur J Immunol. 2017; 47(8):1317-1323.
PMID: 28608405
PMC: 5757839.
DOI: 10.1002/eji.201747050.
Palma M, Duangkhae P, Douradinha B, Viana I, Rigato P, Dhalia R
Gene Ther. 2017; 24(6):342-352.
PMID: 28414303
DOI: 10.1038/gt.2017.25.
Peng Y, Li L
Int J Clin Exp Pathol. 2015; 8(3):3127-31.
PMID: 26045828
PMC: 4440137.
Devaiah B, Singer D
Front Immunol. 2014; 4:476.
PMID: 24391648
PMC: 3868913.
DOI: 10.3389/fimmu.2013.00476.
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.
Forlani G, Abdallah R, Accolla R, Tosi G
Front Microbiol. 2013; 4:234.
PMID: 23986750
PMC: 3749491.
DOI: 10.3389/fmicb.2013.00234.
Multiple histone methyl and acetyltransferase complex components bind the HLA-DRA gene.
Choi N, Boss J
PLoS One. 2012; 7(5):e37554.
PMID: 22701520
PMC: 3365104.
DOI: 10.1371/journal.pone.0037554.
Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication.
Tosi G, Forlani G, Andresen V, Turci M, Bertazzoni U, Franchini G
J Virol. 2011; 85(20):10719-29.
PMID: 21813598
PMC: 3187506.
DOI: 10.1128/JVI.00813-11.
The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis.
Xu Y, Luchsinger L, Lucey E, Smith B
Am J Respir Cell Mol Biol. 2010; 44(6):898-905.
PMID: 20705943
PMC: 3135849.
DOI: 10.1165/rcmb.2009-0416OC.
Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.
Bhat K, Truax A, Greer S
J Biol Chem. 2010; 285(34):25893-903.
PMID: 20538595
PMC: 2923977.
DOI: 10.1074/jbc.M110.127746.
Regulation of IL-17 expression by the developmental pathway of CD4 T cells in the thymus.
Sofi M, Liu Z, Zhu L, Yu Q, Kaplan M, Chang C
Mol Immunol. 2010; 47(6):1262-8.
PMID: 20080304
PMC: 2830291.
DOI: 10.1016/j.molimm.2009.12.010.
Regulating the activity of class II transactivator by posttranslational modifications: exploring the possibilities.
Wu X, Kong X, Luchsinger L, Smith B, Xu Y
Mol Cell Biol. 2009; 29(21):5639-44.
PMID: 19720744
PMC: 2772741.
DOI: 10.1128/MCB.00661-09.
Elevated IL-6 expression in CD4 T cells via PKCtheta and NF-kappaB induces Th2 cytokine production.
Sofi M, Li W, Kaplan M, Chang C
Mol Immunol. 2009; 46(7):1443-50.
PMID: 19181387
PMC: 2757281.
DOI: 10.1016/j.molimm.2008.12.014.
Identification of CIITA regulated genetic module dedicated for antigen presentation.
Krawczyk M, Seguin-Estevez Q, Leimgruber E, Sperisen P, Schmid C, Bucher P
PLoS Genet. 2008; 4(4):e1000058.
PMID: 18437201
PMC: 2278383.
DOI: 10.1371/journal.pgen.1000058.
MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
Zhou X, Jiang Y, Lu L, Ding Q, Jiao Z, Zhou Y
Immunology. 2007; 122(4):476-85.
PMID: 17645498
PMC: 2266042.
DOI: 10.1111/j.1365-2567.2007.02674.x.
Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.
Bode K, Schroder K, Hume D, Ravasi T, Heeg K, Sweet M
Immunology. 2007; 122(4):596-606.
PMID: 17635610
PMC: 2266046.
DOI: 10.1111/j.1365-2567.2007.02678.x.
Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes.
Krawczyk M, Leimgruber E, Seguin-Estevez Q, Dunand-Sauthier I, Barras E, Reith W
Nucleic Acids Res. 2006; 35(2):595-605.
PMID: 17175541
PMC: 1802633.
DOI: 10.1093/nar/gkl980.
Overexpression of CIITA in T cells aggravates Th2-mediated colitis in mice.
Kim T, Park H, Choi E, Jung K
J Korean Med Sci. 2006; 21(5):877-82.
PMID: 17043423
PMC: 2721999.
DOI: 10.3346/jkms.2006.21.5.877.
Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
Tosi G, Pilotti E, Mortara L, De Lerma Barbaro A, Casoli C, Accolla R
Proc Natl Acad Sci U S A. 2006; 103(34):12861-6.
PMID: 16908858
PMC: 1568938.
DOI: 10.1073/pnas.0601589103.
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.
Loza M, Foster S, Peters S, Penn R
Blood. 2005; 107(5):2052-60.
PMID: 16278302
PMC: 1895713.
DOI: 10.1182/blood-2005-08-3265.